| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.61 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |